Season Five Finale of "Married to Medicine" Will Make You Sick, In a Good Way!
When it comes to medical dramas, the ladies of "Married to Medicine," say skip the scripted dramas and go straight for their reality show. Season Five's finale airs on March 2nd and two of the stars join Cheddar for a sneak peak.
Toya Bush-Harris and Dr. Contessa Metcalfe say they have enjoyed being on the show immensely. For the pair, "Married to Medicine" has allowed them to better understand themselves and their relationships with their husbands.
Dr. Contessa says this show is all about them being honest and transparent with their lives. They are happy to put their issues and struggles out there because they believe other couples can learn from their real conversations and issues.
Jason Moser, analyst and adviser at the Motley Fool, shares thoughts on recent tech earnings, including what’s behind Google’s share price drop and why A.I. could be Microsoft’s ‘iPhone moment.’
CEOs of social media platforms like Facebook, TikTok, and more meet with lawmakers Wednesday about how they are protecting children from sexual exploitation.
San Francisco 49ers president Al Guido discusses what goes into preparing for Super Bowl LVIII, building a championship-ready team, and how Taylor Swift and streaming are both bringing new fans to the NFL.
A $1 billion loss from a six-week strike did not crash GM's net income last year, which instead rose 12% — and the automaker expects improvement in 2024, too.
Accrue CEO and founder Michael Hershfield explains why Americans' credit card delinquencies are on the rise, advice on what can help, and the key difference between Boomers and Gen Z when it comes to money.
Senior Economist at Morning Consult Kayla Bruun shares thoughts on what to expect from the Fed's January meeting and where monetary policy is headed, as well as how consumers are faring.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
